Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01384435
Other study ID # KPS1203
Secondary ID
Status Completed
Phase Phase 2
First received June 23, 2011
Last updated November 29, 2012

Study information

Verified date March 2012
Source Kissei Pharmaceutical Co., Ltd.
Contact n/a
Is FDA regulated No
Health authority Japan: Ministry of Health, Labor and Welfare
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of KPS-0373 compared to placebo in patients with Spinocerebellar Degeneration (SCD).


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Japanese SCD patients with mild to moderate ataxia

Exclusion Criteria:

- Patients with secondary ataxia

- Patients with clinically significant hepatic, renal, or cardiovascular dysfunction

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Intervention

Drug:
KPS-0373

KPS-0373

KPS-0373

KPS-0373

Placebo


Locations

Country Name City State
Japan Japan Tokyo and Other Japanese City

Sponsors (1)

Lead Sponsor Collaborator
Kissei Pharmaceutical Co., Ltd.

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in Scale for the assessment and rating of ataxia (SARA) 24 weeks No
Secondary Change from baseline in patient improvement impression of activities of daily living 24 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT04779671 - Effects of the Fully Immersive VR Cognitive Training Based on Leisure Activities for the Elderly With MCI and SCD. N/A
Completed NCT02065596 - Hematopoietic Stem Cell Transplant for Sickle Cell Disease Phase 1
Enrolling by invitation NCT03655223 - Early Check: Expanded Screening in Newborns
Recruiting NCT03926351 - High Dose Omega 3 in People at Risk for Dementia Phase 2
Recruiting NCT05604547 - Exploring Near Infrared Spectroscopy (NIRS) Technologies for Assessment of Muscle Physiology, Tissue Oxygenation, and Blood Flow in Patients With Sickle Cell Disease (SCD) N/A
Recruiting NCT06335836 - The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)
Not yet recruiting NCT05682469 - Effects and Mechanism of the Fully Immersive Virtual Reality Cognitive Training Based on Leisure Activities N/A
Recruiting NCT06120361 - The Swedish BioFINDER - Primary Care Study
Recruiting NCT06122415 - The Swedish BioFINDER - Memory Clinic Study